Dominiek Monserez

Dr. Dominiek Monserez

orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2020 in Oral Oncology
Verified
Journal Article
Open access
FLFlorence van Lanschot
Florence van Lanschot
YKYoram P. Klazen
Yoram P. Klazen
MRMaria De Ridder
Maria De Ridder
HMHetty Mast
Hetty Mast
IHIvo Ten Hove
Ivo Ten Hove
SKSenada Koljenović
Senada Koljenović
Depth of invasion (DOI) is the most important predictor for lymph node metastasis (LNM) in early stage (T1-T2) oral cancer. The aim of this study is to validate the cut-off value of 4 mm on which the decision to perform an Elective Neck Dissection (END) is made. We performed a retrospective study in patients with pathologically proven early stage oral cavity squamous cell carcinoma (OCSCC) without clinical or radiological signs of LNM, who were treated between 2013 and 2018. An END was performed when DOI was ≥ 4 mm and a watchful waiting protocol was applied in patients with DOI < 4 mm. Three hundred patients were included. END was performed in 77% of patients with DOI ≥ 4 mm, of which 36% had occult LNM (pN+). Patients in the watchful waiting group (48%) developed a regional recurrence in 5.2% for DOI < 4 mm and 24.1% for DOI ≥ 4 mm. For DOI ≥ 4 mm, regional recurrence free survival was higher for patients who were treated with END compared to watchful waiting (p = 0.002). A Receiver-Operator-Curve -analysis showed that a DOI cut-off value of 4.0 mm was the optimal threshold for the prediction of occult LNM (95.1% sensitivity, 52.9% specificity). A DOI of ≥ 4 mm is an accurate cut-off value for performing an END in early stage OCSCC. END results in higher survival rates and lower regional recurrence rates in patients with DOI ≥ 4 mm.

20 August 2013 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
AAA. Al‐Mamgani
A. Al‐Mamgani
PRP.H. Rooij
P.H. Rooij
DWD.P. Woutersen
D.P. Woutersen
RMR. Mehilal
R. Mehilal
LTL. Tans
L. Tans
R.R.J.
R.J.

15 April 2021 in Cancers
Verified
Journal Article
Open access
PDF file
LLLorraine Lauwerends
Lorraine Lauwerends
HGHidde Galema
Hidde Galema
Jose HardilloJose Hardillo
Jose Hardillo
ASAniel Sewnaik
Aniel Sewnaik
DMDominiek Monserez
Dominiek Monserez
SKStijn Keereweer
Stijn Keereweer
Laryngeal cancer is a prevalent head and neck malignancy, with poor prognosis and low survival rates for patients with advanced disease. Treatment consists of unimodal therapy through surgery or radiotherapy in early staged tumors, while advanced stage tumors are generally treated with multimodal chemoradiotherapy or (total) laryngectomy followed by radiotherapy. Still, the recurrence rate for advanced laryngeal cancer is between 25 and 50%. In order to improve surgical resection of laryngeal cancer and reduce local recurrence rates, various intraoperative optical imaging techniques have been investigated. In this systematic review, we identify these technologies, evaluating the current state and future directions of optical imaging for this indication. Narrow-band imaging (NBI) and autofluorescence (AF) are established tools for early detection of laryngeal cancer. Nonetheless, their intraoperative utility is limited by an intrinsic inability to image beyond the (sub-)mucosa. Likewise, contact endoscopy (CE) and optical coherence tomography (OCT) are technically cumbersome and only useful for mucosal margin assessment. Research on fluorescence imaging (FLI) for this application is sparse, dealing solely with nonspecific fluorescent agents. Evidently, the imaging modalities that have been investigated thus far are generally unsuitable for deep margin assessment. We discuss two optical imaging techniques that can overcome these limitations and suggest how they can be used to achieve adequate margins in laryngeal cancer at all stages.

1 December 2011 in Radiotherapy and Oncology
Verified
Journal Article
Closed access
PLPeter C. Levendag
Peter C. Levendag
DTDavid N. Teguh
David N. Teguh
FKFatma Keskin-Cambay
Fatma Keskin-Cambay
AAAbrahim Al-Mamgani
Abrahim Al-Mamgani
PRPeter van Rooij
Peter van Rooij
SOSarah O.S. Osman
Sarah O.S. Osman

18 November 2017 in Clinical Otolaryngology
Verified
Journal Article
Closed access
PDF file
CCC.J.I. Caspers
C.J.I. Caspers
EDE.A.C. Dronkers
E.A.C. Dronkers
DMDominiek Monserez
Dominiek Monserez
MWM.H. Wieringa
M.H. Wieringa
RJR.J. Baatenburg de Jong
R.J. Baatenburg de Jong
Jose HardilloJose Hardillo
Jose Hardillo

1 September 2012 in Oral Oncology
Verified
Journal Article
Closed access
AAAbrahim Al-Mamgani
Abrahim Al-Mamgani
DMDominiek Monserez
Dominiek Monserez
PRPeter van Rooij
Peter van Rooij
GVGerda M. Verduijn
Gerda M. Verduijn
JHJose A.U. Hardillo
Jose A.U. Hardillo
PLPeter C. Levendag
Peter C. Levendag